Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-04

Clinical Trial Update: Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing two dosing schedules for hypofractionated image-guided radiation therapy in melanoma and ovarian cancer. The trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma, Ovarian Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING